Biogen Inc. (NASDAQ: BIIB) has been going through a rough patch for some time as the company's popular products faced competition and
BIIB Stock: Is Biogen an investment worth trying now?
Categories
Health Care
Bristol Myers Squibb (BMY) Earnings: 3Q22 Key Numbers
Bristol Myers Squibb (NYSE: BMY) reported revenues of $11.2 billion for the third quarter of 2022, down 3% from the same period
Agilysys, Inc (AGYS) Q2 2023 Earnings Call Transcript
Agilysys, Inc (NASDAQ:AGYS) Q2 2023 Earnings Call dated Oct. 25, 2022. Corporate Participants: Jessica Hennessy -- Senior Director of Corporate Strategy and Investor Relations
Centene Corporation (CNC) Q3 2022 Earnings Call Transcript
Centene Corporation (NYSE:CNC) Q3 2022 Earnings Call dated Oct. 25, 2022. Corporate Participants: Jennifer Gilligan -- Senior Vice President of Investor Relations Sarah M.
Novartis AG (NVS) Q3 2022 Earnings Call Transcript
Novartis AG (NYSE: NVS) Q3 2022 earnings call dated Oct. 25, 2022 Corporate Participants: Samir Shah -- Global Head of Investor Relations Vasant Narasimhan -- Chief
Biogen Inc. (BIIB) Q3 2022 Earnings Call Transcript
Biogen Inc. (NASDAQ: BIIB) Q3 2022 earnings call dated Oct. 25, 2022 Corporate Participants: Mike Hencke -- Head, Investor Relations Michel Vounatsos -- Chief Executive Officer
Infographic: Highlights from Biogen’s (BIIB) Q3 2022 earnings results
Pharma giant Biogen Inc. (NASDAQ: BIIB) on Tuesday announced financial results for the third quarter of 2022, reporting a double-digit drop in
Quest Diagnostics Inc. (DGX) Q3 2022 Earnings Call Transcript
Quest Diagnostics Inc. (NYSE: DGX) Q3 2022 earnings call dated Oct. 20, 2022 Corporate Participants: Shawn Bevec -- Vice President Investor Relations Stephen H.
Abbott (ABT) Q3 2022 Earnings Call Transcript
Abbott (NYSE: ABT) Q3 2022 earnings call dated Oct. 19, 2022 Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing, and Acquisition
Infographic: Highlights of Intuitive Surgical’s Q3 2022 earnings
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) said its third-quarter adjusted earnings remained unchanged year-over-year, while revenues increased in double digits.
Key highlights from Abbott (ABT) Q3 2022 earnings results
Abbott (NYSE: ABT) reported third quarter 2022 earnings results today. Sales decreased 4.7% year-over-year to $10.4 billion. On an organic basis, sales
Intuitive Surgical, Inc. (ISRG) Q3 2022 Earnings Call Transcript
Intuitive Surgical, Inc. (NASDAQ: ISRG) Q3 2022 earnings call dated Oct. 18, 2022 Corporate Participants: Brian King -- Treasurer and Head of Investor Relations
UnitedHealth Group (UNH) Earnings: 3Q22 Key Numbers
UnitedHealth Group (NYSE: UNH) reported third quarter 2022 earnings results today. Revenues grew 12% year-over-year to $80.9 billion. Net earnings attributable to
Walgreens Boots Alliance, Inc. (WBA) Q4 2022 Earnings Call Transcript
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) Q4 2022 earnings call dated Oct. 13, 2022 Corporate Participants: Tiffany Kanaga -- Vice President, Global Investor Relations
Johnson & Johnson (JNJ) offers long-term stability. Is the stock a buy?
Johnson & Johnson (NYSE: JNJ) has stayed largely unaffected by the COVID crisis and macroeconomic headwinds so far, which allowed the healthcare
Why AngioDynamics (ANGO) deserves a place on investors’ watchlist
The market reopening has created a conducive atmosphere to carry out elective medical procedures which were deferred on a large scale during
ANGO Earnings: AngioDynamics Q1 loss widens. Revenue up 6%
AngioDynamics Inc. (NASDAQ: ANGO) on Friday reported a wider loss for the first quarter of 2023, despite a modest increase in revenues.
Accolade, Inc. (ACCD) Q2 2023 Earnings Call Transcript
Accolade, Inc. (NASDAQ: ACCD) Q2 2023 earnings call dated Oct. 06, 2022 Corporate Participants: Todd Friedman -- Senior Vice President of Investor Relations Rajeev
Angiodynamics Inc (ANGO) Q1 2023 Earnings Call Transcript
Angiodynamics Inc (NASDAQ: ANGO) Q1 2023 earnings call dated Oct. 06, 2022 Corporate Participants: Jim Clemmer -- President and Chief Executive Officer Stephen A.
Prime Medicine is the next big biotech to pursue IPO. Here’s all you need to know
After a soft start to the year, the IPO market has witnessed muted activity so far though a few big companies entered
FactSet Research Systems Inc. (FDS) Q4 2022 Earnings Call Transcript
FactSet Research Systems Inc. (NYSE: FDS) Q4 2022 earnings call dated Sep. 22, 2022 Corporate Participants: Kendra Brown -- Head of Investor Relations Philip